United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$143Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
No investor was named in the report.
Reported by masshightech.comSEC filing: $10M sold, first sale Aug 2012
Reported by masshightech.comSEC filing: $3.0M sold, first sale Dec 2009
Reported by altassets.comSEC filing: $25M sold, first sale Nov 2009
From the SEC filings it signed: 1 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novartis Venture FundNovartis Option Fund
Lilly VenturesBio*One Capital
RA Capital ManagementL
Wellington Management
Cormorant Asset Management
Samsara BioCapitalMissing a round, or an investor who was in one? Tell us.
FORMA Therapeutics's investors include Novartis Venture Fund, Novartis Option Fund, Lilly Ventures, Bio*One Capital and RA Capital Management, and 3 more on record. RA Capital Management led its latest round.
FORMA Therapeutics has raised $143M across 5 rounds since 2008.
FORMA Therapeutics's most recent round was a Series D of $100M in Dec 2019, led by RA Capital Management.
Its most recent round, $100M in Dec 2019, is also its largest on record.
FORMA Therapeutics's first round on record, in Apr 2008, was backed by Novartis Venture Fund and Novartis Option Fund.
FORMA Therapeutics's latest named round is a Series D, in Dec 2019.
FORMA Therapeutics is based in the United States.
RA Capital Management led the Series D in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
